Natera, Inc.
NASDAQ: NTRA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Steven Leonard Chapman
- Employees
- 4,424
- Headquarters
- Austin, United States
- IPO year
- 2015
- Market cap
- $33.1B
- Website
- https://www.natera.com
Loading NTRA…
Loading profile data…Frequently asked questions about NTRA
What does Natera, Inc. (NTRA) do?
Natera, Inc. is a diagnostics company focused on developing and commercializing a wide array of molecular testing services globally. Its portfolio includes several key offerings: Panorama, a non-invasive prenatal test (NIPT) that screens for chromosomal abnormalities in a fetus using a blood sample from the mother, and also determines zygosity i...
Where does NTRA trade?
Natera, Inc. (NTRA) trades on the NASDAQ Global Select.
What sector is NTRA in?
Natera, Inc. (NTRA) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Natera, Inc.?
Steven Leonard Chapman is the chief executive officer of Natera, Inc. (NTRA).
Where is Natera, Inc. headquartered?
Natera, Inc. is headquartered in United States.
Does NTRA pay a dividend?
Natera, Inc. (NTRA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NTRA go public?
Natera, Inc. (NTRA) completed its initial public offering in 2015.